Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 28th January 2013
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel
VMD to ban some flukicides
Use of certain flukicides to be banned in milk-producing animals

The VMD have announced a ban on the use of certain flukicides in animals producing milk for human consumption. Speaking last week at the Animal Health Distributors Association conference, Paul Green, director of operations at the directorate said the decision had come from the European Commission (EC). The ban aims to "clarify and harmonise" the advice on using these types of products across the member states.

Mr Green said: "The advice confirms that products containing clorsulon, closantel, nitroxinil, triclabendazole and rafoxanide are not authorised for use in animals producing milk for human consumption, including during the dry period."

However, he added that products containing one of these compounds as their sole active substance will be subject to "specific directions", with regards to their use in heifers and ewes prior to the first calving or lambing. For example, clostanel can be given to pregnant cattle, but not during the second half of pregnancy, whereas triclabendazole cannot be used within the year prior to the first lambing or kidding in sheep and goats respectively.

No UK-authorised products contain rafoxanide, and clorsulon is currently only included in UK products in combination with a second active substance, meaning there are no special circumstances with either of these two substances.

According to the directorate, the decision by the EC comes after a "community interest referral", which is a change initiated by concerns regarding the protection of the EU's human and/or animal health. As a result of the decision there will be major changes to the labelling of affected products across the EU. Mr Green said that the marketing authorisation holders (MAHs) concerned were taking the "necessary steps" to introduce the new labelling. Products containing the new advice will start to become available "in about six months time".

More information and a complete list of the specific directions is available on the VMD's website.

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.